Home / Resource Library / Risk of Severe Infections Secondary to the Use of Targeted Therapies in Hematological Malignancies

Risk of Severe Infections Secondary to the Use of Targeted Therapies in Hematological Malignancies

Study examined risk of infection from targeted treatments in patients with blood cancers.